Q1 2021 Arcticzymes Technologies ASA Earnings Call Transcript
So good morning. Welcome to the Q1 presentation. For the agenda, here we go in the usual fashion, where we go through the highlights for the quarter. Then we will move on to giving you a business update. Børge will orientate you through the financials. And then we will finish it off quite quickly.
So for the highlights for the quarter. What we see is for ArcticZymes, it is actually our first quarter as pure enzymes company and for us it's been an outstanding quarter. We've actually achieved our best quarterly performance ever, achieving NOK 40.4 million in sales for the quarter. Profitability remains strong. We've achieved NOK 25.8 million in EBITDA.
When it comes to the 3 segments -- the market segments we serve, each of those has grown. And what we've also seen there, in particular, the molecular research sales, we see now it's started to reestablish to pre pandemic levels. On top of that, we've -- we've successfully upscaled the manufacturing process of our SAN HQ enzyme by over 100-fold factor, and that's very important in driving
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
